BridgeMD
New treatment option for Elective Surgical Procedures
Official title Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair
ClinicalTrials.gov ID: NCT04894864
What this study is testing
What is Opioid-Based Anesthesia-Analgesia Strategy?
Opioid-Based Anesthesia-Analgesia Strategy is an investigational medicine, being studied as a potential treatment for elective surgical procedures.
Also referred to as Opioid-Based Anesthesia, OBA-A.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Open Abdominal Aortic Aneurysm (AAA) repair is a high-risk surgical procedure accompanied by intense endocrine and metabolic responses to surgical stress, with subsequent activation of the inflammatory cascade, cytokine and acute-phase protein release, and bone marrow activation. There is a proven correlation of surgical stress, which patients undergoing open AAA repair are subjected to, with patient outcome, morbidity/mortality, intensive care unit stay and overall length of stay.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Patient Consent
- Age between 40 and 85 years old
- Patients undergoing Elective Open Abdominal Aortic Infrarenal Aneurysm Repair
You likely can't join if
- Immunocompromised patients
- Patients with active infection
- Reoperation on the aorta
- Inflammatory bowel Disease
- Malignancy
- Chronic Inflammatory conditions (e.g. Rheymatoid arthritis, Psoriatic arthritis)
See the full eligibility criteria
- Patient Consent
- Age between 40 and 85 years old
- Patients undergoing Elective Open Abdominal Aortic Infrarenal Aneurysm Repair
- Immunocompromised patients
- Patients with active infection
- Reoperation on the aorta
- Inflammatory bowel Disease
- Malignancy
- Chronic Inflammatory conditions (e.g. Rheymatoid arthritis, Psoriatic arthritis)
- Chronic corticosteroid or immunosuppressive drug use
- Intraoperative transfusion with \>2 units of packed Red Blood Cells
The study team makes the final eligibility decision.
Where it's taking place
- Heraklion, Crete, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Heraklion, Crete, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.